<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308111</url>
  </required_header>
  <id_info>
    <org_study_id>747-302</org_study_id>
    <nct_id>NCT02308111</nct_id>
  </id_info>
  <brief_title>Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis</brief_title>
  <acronym>COBALT</acronym>
  <official_title>A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intercept Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intercept Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Biliary Cholangitis (PBC) is a serious, life-threatening, bile acid related liver
      disease of unknown cause. Without treatment, it frequently progresses to liver fibrosis and
      eventual cirrhosis requiring liver transplantation or resulting in death. The investigational
      drug, Obeticholic Acid (OCA) is a modified bile acid and FXR agonist that is derived from the
      primary human bile acid chenodeoxycholic acid. The key mechanisms of action of OCA, including
      its choleretic, anti-inflammatory, and anti-fibrotic properties, underlie its
      hepatoprotective effects and result in attenuation of injury and improved liver function in a
      cholestatic liver disease such as PBC. The study will assess the effect of OCA compared to
      placebo, combined with stable standard care, on clinical outcomes in PBC patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Phase 4, double-blind, randomized, placebo-controlled, multicenter study is being
      undertaken at up to 170 sites internationally to evaluate the effect of OCA on clinical
      outcomes in 428 subjects with PBC. The study will include a screening period of up to 8
      weeks, requiring two clinic visits. Eligible participants will be randomly allocated (1:1) to
      treatment with either OCA 5 mg or matching placebo tablets, taken orally once daily for the
      majority of subjects; dose and frequency will be modified for subjects with cirrhosis and
      classified as Child-Pugh B or C. Randomization will be stratified by standard treatment with
      UDCA (yes/no) and baseline liver function. The treatment period involves clinic visits
      approximately every 3 months. At the 3 month visit or any study visit thereafter, if study
      treatment is tolerated, participants' dose should be titrated per protocol in a blinded
      manner eg for participants who are non-cirrhotic or classified as Child-Pugh A and randomized
      to OCA, they should receive the maximum daily dose of 10 mg OCA, those on placebo continue to
      receive placebo. Subsequently, daily dosage may return to 5 mg if necessary for these
      participants who are non-cirrhotic or classified as Child-Pugh A, but should be increased to
      10 mg if possible, based on tolerability and clinical judgment. Safety and tolerability will
      be assessed by monitoring adverse events and vital signs, and blood and urine testing. The
      study is event driven and total duration will be determined by the time required to accrue
      approximately 127 primary endpoint events, estimated to be approximately 10 years. Subjects
      are expected to have a minimum follow-up time of approximately 6 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite endpoint of any of the five listed adjudicated events</measure>
    <time_frame>Time to accrue approximately 127 primary endpoint events, estimated to be approximately 10 years</time_frame>
    <description>Primary endpoint events include:
death
liver transplant
MELD score ≥15
uncontrolled ascites
hospitalization for new onset or recurrence of any of the following:
variceal bleed
hepatic encephalopathy
spontaneous bacterial peritonitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First occurrence of each of the listed individual events</measure>
    <time_frame>Time to first occurrence from date of randomization until the date of first documented progression or date of death from any cause, whichever came first, up to 10 years</time_frame>
    <description>Individual events include:
death
liver transplant
MELD score &gt;15
uncontrolled ascites
hospitalization for new onset or recurrence of any of the following:
variceal bleed
hepatic encephalopathy
spontaneous bacterial peritonitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of liver-related death</measure>
    <time_frame>Time to first occurrence from date of randomization until the date of first documented progression or date of death from any cause, whichever came first, up to 10 years</time_frame>
    <description>To assess the effect of OCA compared to placebo on time to occurrence of liver-related death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression to cirrhosis</measure>
    <time_frame>Time to first occurrence from date of randomization until the date of first documented progression or date of death from any cause, whichever came first, up to 10 years</time_frame>
    <description>To assess the effect of OCA compared to placebo on progression to cirrhosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to occurrence of hepatocellular carcinoma (HCC)</measure>
    <time_frame>Time to first occurrence from date of randomization until the date of first documented progression or date of death from any cause, whichever came first, up to 10 years</time_frame>
    <description>To assess the effect of OCA compared to placebo on time to occurrence of hepatocellular carcinoma (HCC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline in blilirubin as a marker of liver biochemistry</measure>
    <time_frame>Samples will be measured at Baseline and Months 3, 6, 9 and 12 for 10 Years</time_frame>
    <description>bilirubin (total and conjugated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline in aspartate aminotransferase (AST) as a marker of liver biochemistry</measure>
    <time_frame>Samples will be measured at Baseline and Months 3, 6, 9 and 12 for 10 Years</time_frame>
    <description>aspartate aminotransferase (AST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline in alanine aminotransferase (ALT) as a marker of liver biochemistry</measure>
    <time_frame>Samples will be measured at Baseline and Months 3, 6, 9 and 12 for 10 Years</time_frame>
    <description>alanine aminotransferase (ALT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline in alkaline phosphatase (ALP) as a marker of liver biochemistry</measure>
    <time_frame>Samples will be measured at Baseline and Months 3, 6, 9 and 12 for 10 Years</time_frame>
    <description>alkaline phosphatase (ALP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline in gamma-glutamyl transferase (GGT) as a marker of liver biochemistry</measure>
    <time_frame>Samples will be measured at Baseline and Months 3, 6, 9 and 12 for 10 Years</time_frame>
    <description>gamma-glutamyl transferase (GGT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in IgM as a marker of inflammation</measure>
    <time_frame>Samples will be measured at Baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>IgM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in C-reactive protein (CRP) as a marker of inflammation</measure>
    <time_frame>Samples will be measured at Baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>C-reactive protein (CRP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in tumor necrosis factor-alpha (TNF-α) as a marker of inflammation</measure>
    <time_frame>Samples will be measured at Baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>tumor necrosis factor-alpha (TNF-α)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in fibroblast growth factor-19 (FGF-19) as a marker of inflammation</measure>
    <time_frame>Samples will be measured at Baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>fibroblast growth factor-19 (FGF-19)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in cytokeratin-18 (CK-18) as a marker of liver fibrosis</measure>
    <time_frame>Samples will be measured at baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>cytokeratin-18 (CK-18)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in enhance liver fibrosis (ELF) test as a marker of liver fibrosis</measure>
    <time_frame>Samples will be measured at baseline and Months 6 and 12 for up to 10 Years</time_frame>
    <description>enhance liver fibrosis (ELF) test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in trasnsient elastography as a marker of liver fibrosis</measure>
    <time_frame>Liver fibrosis will be measured at baseline and Month 12 for up to 10 Years</time_frame>
    <description>Liver fibrosis measured using transient Elastography with Fibroscan®</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">428</enrollment>
  <condition>Liver Cirrhosis, Biliary</condition>
  <arm_group>
    <arm_group_label>Obeticholic Acid (OCA) 5 mg to 10 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obeticholic Acid (OCA) 5 mg for a minimum 3 months and then titrating up to a maximum 10 mg for the remainder of the trial (based on tolerability and Child Pugh Score).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Obeticholic Acid (OCA)</intervention_name>
    <description>Non-cirrhotic and classified as Child-Pugh Class A: 5 mg tablet of OCA once daily titrating up to a maximum of 10 mg OCA once daily based on tolerability at 3 months for the duration of the study (majority of patients).
Cirrhotic and classified as Child-Pugh Class B and C: 5 mg tablet of OCA once weekly titrating up to 5 mg OCA twice weekly based on tolerability at 3 months, subsequently titrating up to 10 mg OCA twice weekly based on tolerability (maximum for Child-Pugh C) and subsequently titrating up to 5 mg daily based on tolerability (maximum for Child-Pugh B) for the duration of the study.</description>
    <arm_group_label>Obeticholic Acid (OCA) 5 mg to 10 mg</arm_group_label>
    <other_name>6alpha-ethylchenodeoxycholic acid (6-ECDCA)</other_name>
    <other_name>INT-747</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One tablet daily (or a lower frequency depending on Child Pugh score) for the remainder of the study</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Definite or probable PBC diagnosis (consistent with American Association for the Study
             of Liver Diseases [AASLD] and the European Association for the Study of the Liver
             [EASL] practice guidelines; Lindor 2009; EASL 2009), as demonstrated by the presence
             of ≥2 of the following 3 diagnostic factors:

               -  History of elevated Alkaline phosphatase levels for at least 6 months prior to
                  Day 0

               -  Positive antimitochondrial antibody (AMA) titer or if AMA negative or in low
                  titer (&lt;1:80) PBC-specific antibodies (anti-GP210 and/or anti-SP100 and/or
                  antibodies against the major M2 components [PDC-E2, 2-oxo-glutaric acid
                  dehydrogenase complex])

               -  Liver biopsy consistent with PBC

          2. A mean total bilirubin &gt;ULN and ≤3x ULN or an ALP &gt;5x ULN

          3. Age ≥18 years

          4. Taking Ursodeoxycholic acid (UDCA) for at least 12 months (stable dose for ≥3 months)
             prior to Day 0, or unable to tolerate UDCA (no UDCA for ≥3 months) prior to Day 0

          5. Contraception: Female subjects of childbearing potential must use ≥1 effective method
             of contraception during the trial and until 30 days following the last dose of
             investigational product. Effective methods of contraception are considered to be:

               -  Hormonal (e.g. contraceptive pill, patch, intramuscular implant or injection; or

               -  Double barrier method, i.e. (a) condom (male or female) or (b) diaphragm, with
                  spermicide; or

               -  Intrauterine device (IUD); or

               -  Vasectomy (partner); or

               -  Abstinence, if in line with the preferred and usual lifestyle of the subject

          6. Must provide written informed consent and agree to comply with the study protocol

        Exclusion Criteria:

          1. History or presence of other concomitant liver diseases including:

               -  Hepatitis C virus infection

               -  Active Hepatitis B infection; however, subjects who have seroconverted (hepatitis
                  B surface antigen and hepatitis B e antigen negative) may be included in this
                  study after consultation with the medical monitor

               -  Primary sclerosing cholangitis (PSC)

               -  Alcoholic liver disease

               -  Definite autoimmune liver disease or overlap hepatitis

               -  Nonalcoholic steatohepatitis (NASH)

               -  Gilbert's Syndrome

          2. Presence of clinical complications of PBC or clinically significant hepatic
             decompensation, including:

               -  History of liver transplant, current placement on a liver transplant list, or
                  current Model of End Stage Liver Disease (MELD) score &gt;12. Subjects who are
                  placed on a transplant list despite a relatively early disease stage (for example
                  per regional guidelines) may be eligible as long as they do not meet any of the
                  other exclusion criteria

               -  Cirrhosis with complications, including history (within the past 12 months) or
                  presence of:

                    -  Variceal bleed

                    -  Uncontrolled ascites

                    -  Encephalopathy

                    -  Spontaneous bacterial peritonitis

               -  Known or suspected HCC

               -  Prior transjugular intrahepatic portosystemic shunt procedure

               -  Hepatorenal syndrome (type I or II) or screening serum creatinine &gt;2 mg/dL (178
                  μmol/L)

          3. Mean total bilirubin &gt;5x ULN

          4. Subjects who have undergone gastric bypass procedures (gastric lap band is acceptable)
             or ileal resection or plan to undergo either of these procedures

          5. Other medical conditions that may diminish life expectancy, including known cancers
             (except carcinomas in situ or other stable, relatively benign conditions such as
             chronic lymphatic leukemia)

          6. If female: plans to become pregnant, known pregnancy or a positive urine pregnancy
             test (confirmed by a positive serum pregnancy test), or lactating

          7. Known history of human immunodeficiency virus infection

          8. Medical conditions that may cause nonhepatic increases in ALP (eg, Paget's disease or
             fractures within 3 months)

          9. Other clinically significant medical conditions that are not well controlled or for
             which medication needs are anticipated to change during the study

         10. History of alcohol abuse or other substance abuse within 1 year prior to Day 0

         11. Participation in another investigational product, biologic, or medical device study
             within 30 days prior to Screening. Participation in a previous study of OCA is allowed
             with 3 months washout prior to enrollment in this study

         12. Mental instability or incompetence, such that the validity of informed consent or
             ability to be compliant with the study is uncertain

         13. History of known or suspected clinically significant hypersensitivity to OCA or any of
             its components

         14. UDCA naïve (unless contraindicated)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Shapiro, MD</last_name>
    <role>Study Director</role>
    <affiliation>Intercept Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erin Babcock</last_name>
    <email>erin.babcock@interceptpharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kimberly Fowler</last_name>
    <email>kfowler@interceptpharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Carey</last_name>
      <phone>480-342-1094</phone>
    </contact>
    <investigator>
      <last_name>Elizabeth Carey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Sarmiento</last_name>
      <phone>310-423-6000</phone>
      <email>Laura.Sarmiento@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Vinay Sundaram, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inland Empire Liver Foundation</name>
      <address>
        <city>Rialto</city>
        <state>California</state>
        <zip>92377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvia Huerta, CCRC</last_name>
      <phone>909-883-2999</phone>
      <email>shuerta@ieliverfoundation.com</email>
    </contact>
    <investigator>
      <last_name>Zeid Kayali, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandeep Dhaliwal, M.D.</last_name>
      <phone>916-734-8985</phone>
      <email>sandhaliwal@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Bowlus, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pranali Suryavanshi</last_name>
      <phone>650-721-4288</phone>
      <email>pranali@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Aijaz Ahmed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jada Boyd</last_name>
      <phone>303-724-1866</phone>
      <email>jada.boyd@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Forman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Hepatology Research at CTRB</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Horne, ARNP</last_name>
      <phone>352-273-9464</phone>
      <email>Patrick.horne@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Roberto Firpi-Morell, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33163</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odalys Rodriguez Bravo, RN-BSN</last_name>
      <phone>305-243-4648</phone>
      <email>Obravo@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Cynthia Levy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethany Lane</last_name>
      <phone>404-605-4618</phone>
      <email>Bethany.lane@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Raymond Rubin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Specialists of Georgia</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Ange</last_name>
      <phone>678-388-2050</phone>
      <email>mange@gigeorgia.com</email>
    </contact>
    <investigator>
      <last_name>Aasim Sheikh, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Flamm, MD</last_name>
      <phone>312-908-7280</phone>
      <email>s-flamm@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Flamm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Williams</last_name>
      <phone>773-702-4477</phone>
      <email>mwillia3@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>K. Gautham Reddy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Lee, RN</last_name>
      <phone>317-278-6266</phone>
      <email>lee352@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Raj Vuppalanchi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indianapolis Gastroenterology Research Foundation</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beverly Flamme</last_name>
      <phone>312-865-2959</phone>
      <email>bflamme@indygastro.com</email>
    </contact>
    <investigator>
      <last_name>David Pound, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Siegwald</last_name>
      <phone>502-852-2043</phone>
      <email>angela.siegwald@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Cave, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delainna Bartholomew</last_name>
      <phone>504-988-6902</phone>
      <email>delainna.bartholomew@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Fredric Regenstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Cho</last_name>
      <phone>410-576-5389</phone>
      <email>scho@mdmercy.com</email>
    </contact>
    <investigator>
      <last_name>Paul Thuluvath, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMass Medical School/UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Giansiracusa, RN, CCRC</last_name>
      <phone>774-441-7648</phone>
      <email>donna.giansiracusa@umassmemorial.org</email>
    </contact>
    <investigator>
      <last_name>Gyongyi Szabo, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Gastroenterology, P.A.</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Gruber</last_name>
      <phone>612-870-5596</phone>
      <email>Andrea.gruber@mngastro.com</email>
    </contact>
    <investigator>
      <last_name>Donald Zogg, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Therapy and Advanced Research (STAR)</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Arendale</last_name>
      <phone>601-940-3341</phone>
      <email>earendale@jacksonliverandGI.com</email>
    </contact>
    <investigator>
      <last_name>Brian Borg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City Research Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Lynn</last_name>
      <phone>816-759-5274</phone>
      <email>LLYnn@kcresearchinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Bradley Freilich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Torretta</last_name>
      <phone>314-977-9400</phone>
      <email>torretta@slu.edu</email>
    </contact>
    <investigator>
      <last_name>Bruce Bacon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Regional Medical Center</name>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <zip>07503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maliha Ahmad</last_name>
      <email>ahmadmali@sjhmc.org</email>
    </contact>
    <investigator>
      <last_name>Maliha Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Peterson</last_name>
      <phone>646-962-5302</phone>
      <email>rhp2003@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Sonal Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Vallone</last_name>
      <phone>585-275-4763</phone>
      <email>mailto:chelsea_vallone@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Huang, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Kim-Lee</last_name>
      <phone>215-360-0836</phone>
      <email>GraceKim.Lee@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>K. Rajender Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quality Medical Research, PLLC</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The Liver Institute at Methodist Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Uberu</last_name>
      <phone>214-947-1287</phone>
      <email>CynthiaUberu@mhd.com</email>
    </contact>
    <investigator>
      <last_name>Parvez Mantry, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Texas Digestive Disease Consultants</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Griselda Soto</last_name>
      <phone>214-648-2725</phone>
      <email>Griselda.Soto@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Marlyn Mayo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Baylor All Saints Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Morones</last_name>
      <phone>817-922-2586</phone>
      <email>Sandra.morones@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Manjushree Gautam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI St. Luke's Health Baylor College of Medicine Medical Center-Advanced Liver Therapies</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Dietrich</last_name>
      <phone>713-798-5242</phone>
      <email>bdietrich@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>John Vierling, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Medrano</last_name>
      <email>William.Medrano@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Moises Nevah Rubin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>American Research Corporation at Texas Liver Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Forsyth</last_name>
      <phone>210-253-3426</phone>
      <email>nforsyth@txliver.com</email>
    </contact>
    <investigator>
      <last_name>Eric Lawitz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Digestive Disease Consultants</name>
      <address>
        <city>Southlake</city>
        <state>Texas</state>
        <zip>76092</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Duncker</last_name>
      <phone>817-424-1525</phone>
      <email>cduncker@tddctx.com</email>
    </contact>
    <investigator>
      <last_name>James Trotter, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Centers of America</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>McGuire DVAMC</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Culley-Grammer</last_name>
      <email>Brenda.Culley-Grammer@va.gov</email>
    </contact>
    <investigator>
      <last_name>Velmir Luketic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Liver Clinic</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Everett</last_name>
      <phone>206-386-3201</phone>
      <email>Allison.Everett@swedish.org</email>
    </contact>
    <investigator>
      <last_name>Kris Kowdley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro De Hepatología de La Plata</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>B1902AWL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Mansilla</last_name>
      <phone>54-221-483-8537</phone>
      <email>mariaemansilla@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Raul Eduardo Adrover</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dim Clínica Privada</name>
      <address>
        <city>Ramos Mejía</city>
        <state>Buenos Aires</state>
        <zip>1704</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Cendali</last_name>
      <phone>54-11-4656-2828</phone>
      <email>gloriacendali@clinicadim.com.ar</email>
    </contact>
    <investigator>
      <last_name>Eduardo Fassio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Britanico De Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <state>Caba</state>
        <zip>C1280AEB</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Delgado</last_name>
      <phone>55-11-4309-6807</phone>
      <email>patricia12delgado@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luis Colombato</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Provincial del Centenario</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Juaristi</last_name>
      <phone>54-341-439-3511</phone>
      <email>hepagastro.rosario@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Fernando Bessone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CIPREC - Centro de Investigacion y Prevencion Cardiovascular S.A.</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1119</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florencia Ledesma</last_name>
      <phone>54-114-827-3866</phone>
      <email>fledesma.ciprec@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hugo Fainboim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital De Clinicas University Of Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1120</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Alonso</last_name>
      <phone>54-115-977-5980</phone>
      <email>inealonso@yahoo.com.ar</email>
    </contact>
    <investigator>
      <last_name>Juan Sorda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Italiano</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1181</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Carlone</last_name>
      <phone>5411-4959-0200</phone>
      <phone_ext>4154</phone_ext>
      <email>mauro.carlone@hospitalitaliano.org.ar</email>
    </contact>
    <investigator>
      <last_name>Adrian Gadano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Aleman</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarita Anders</last_name>
      <phone>54-114-8277000</phone>
      <phone_ext>6465</phone_ext>
      <email>margarita.anders@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Mastai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Austral</name>
      <address>
        <city>Buenos Aires</city>
        <zip>B1629AHJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandra Romano</last_name>
      <email>alejandra_romano@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Mendizabal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerry Witton</last_name>
      <phone>612-9515 6006</phone>
      <email>Kerry.Witton@sswahs.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Simone Strasser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nepean Blue Mountains Local Health District</name>
      <address>
        <city>Kingswood</city>
        <state>New South Wales</state>
        <zip>2747</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaaya Kanapathipillai, RA</last_name>
      <phone>61 2 4734 2319</phone>
      <email>Gaaya.Kanapathipillai@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Martin Weltman, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gallipoli Medical Research Foundation</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4120</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Morgan</last_name>
      <phone>+618 82224248</phone>
      <email>joanne.morgan@health.sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Marc LeMire, MBBS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Wundke, RN</last_name>
      <phone>61 8 8204 6989</phone>
      <email>Rachel.Wundke@health.sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Kate Muller, MBBS, FRACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Health - Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Chivers</last_name>
      <phone>61 3 9094 9548</phone>
      <email>Sarah.chivers@monash.edu</email>
    </contact>
    <investigator>
      <last_name>Amanda Nicoll, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleanor Cropp</last_name>
      <phone>61 (0)3 9231 3518</phone>
      <email>Eleanor.CROPP@svha.org.au</email>
    </contact>
    <investigator>
      <last_name>Alex Thompson, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Morales</last_name>
      <phone>‭+61-3-9496-3487</phone>
      <email>brenda.morales@austin.org.au</email>
    </contact>
    <investigator>
      <last_name>Janine French</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wendy Lam, RN</last_name>
      <phone>+61 08 6152 2222</phone>
      <email>wendy.lam@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Sam Galhenage</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AKH, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emina Halilbasic</last_name>
      <phone>+43 140400 47410</phone>
      <email>emina.halilbasic@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Michael Trauner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZA</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derwael Veronique</last_name>
      <phone>3238215210</phone>
      <email>veronique.derwael@uza.be</email>
    </contact>
    <investigator>
      <last_name>Sven Francque, Md Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uz Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liliane Schrijvers</last_name>
      <phone>+32 16 34 16 18</phone>
      <email>liliane.schrijvers@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Frederik Nevens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cub Hôpital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amari Nesrine</last_name>
      <phone>32 2 555 52 70</phone>
      <email>nesrine.amari@erasme.ulb.ac.be</email>
    </contact>
    <investigator>
      <last_name>Christophe Moreno, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Roels</last_name>
      <phone>32 (0)9 332 9459</phone>
      <email>karen.roels@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Anja Geerts</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Ivan Rilsky University Hospital</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dimitar Popov, Md, Phd</last_name>
      <phone>359-2-9526319</phone>
      <email>dr_popov@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Deian Jelev, Md, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary Liver Unit</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N-4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shefina Mawani</last_name>
      <phone>1-403-220-3659</phone>
      <email>shefina.mawani@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Mark Swain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candace Lewis</last_name>
      <phone>1-780-492-8602</phone>
      <email>candacelewis@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Andrew Mason</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Of Manitoba, Health Sciences Centre</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Franklin</last_name>
      <phone>1-204-789-3725</phone>
      <email>CFranklin@exchange.hsc.mb.ca</email>
    </contact>
    <investigator>
      <last_name>Gerald Minuk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre-University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Coltescu</last_name>
      <phone>416-340-5800</phone>
      <phone_ext>6192</phone_ext>
      <email>ccoltesc@uhnresearch.ca</email>
    </contact>
    <investigator>
      <last_name>Aliya Gulamhusein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chum</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 3J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Benjamin</last_name>
      <phone>1-514-890-8000</phone>
      <email>christina.benjamin.chum@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Catherine Vincent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro De Investigaciones Clínicas Viña Del Mar</name>
      <address>
        <city>Viña Del Mar</city>
        <zip>2540364</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Castagneto</last_name>
      <phone>56-32-2891219</phone>
      <email>gcastagneto@institutooncologico.cl</email>
    </contact>
    <investigator>
      <last_name>Francisco Fuster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medicinsk Hepato-Gastroenterologisk Afdeling V, Aarhus Universitetshospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000 C</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisbet Gerdes</last_name>
      <phone>+45 515 048 13</phone>
      <email>lisbgerd@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Hendrik Vilstrup</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet - Hepatologisk klinik</name>
      <address>
        <city>København Ø</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Davidsen</last_name>
      <phone>+45 3545 1031</phone>
      <email>gitte.marianne.davidsen@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Mette Kjaer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense Universityhospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Berg</last_name>
      <email>Anne.berg@rsyd.dk</email>
    </contact>
    <investigator>
      <last_name>Aleksander Krag</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Tallinn Central Hospital</name>
      <address>
        <city>Tallinn</city>
        <state>Harju</state>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peeter Koiva</last_name>
      <phone>372 6207057</phone>
      <email>peeter.koiva@itk.ee</email>
    </contact>
    <investigator>
      <last_name>Triin Remmel, Md, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tartu University Hospital</name>
      <address>
        <city>Tartu</city>
        <zip>51014</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riina Salupere, MD</last_name>
      <phone>372 7318658</phone>
      <email>riina.salupere@kliinikum.ee</email>
    </contact>
    <investigator>
      <last_name>Riina Salupere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virpi Pelkonen</last_name>
      <phone>+358 9 471 72415</phone>
      <email>virpi.pelkonen@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Martti Farkkila</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Turku University Central Hospital, Gastroenterology Outpatient Clinic</name>
      <address>
        <city>Turku,</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanni Anttila</last_name>
      <phone>358 2 313 0332</phone>
      <email>sanni.anttila@tyks.fi</email>
    </contact>
    <investigator>
      <last_name>Kimmo Salminen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Saint-Antoine, A.P.-H.P.</name>
      <address>
        <city>Paris Cedex 12</city>
        <state>Paris</state>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farid Gaouar, MD</last_name>
      <phone>+33 01 71 97 01 17</phone>
      <email>farid.gaouar@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Corpechot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Hôpital HURIEZ</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Suffys</last_name>
      <phone>+33.3.20.44.57.42</phone>
      <email>virginie.suffys@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Mathurin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu De Bordeaux - Hôpital Haut Lévêque</name>
      <address>
        <city>Pessac Cedex</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maude Charbonnier</last_name>
      <phone>+33 0557656311</phone>
      <email>maude.charbonnier@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Victor de Ledinghen, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann-Wolfgang Goethe, Universitaet Frankfurt am Main</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Graf-Dirmeier</last_name>
      <phone>0049 69 6301-87769</phone>
      <email>Sabine.Graf-Dirmeier@kgu.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Zeuzem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie und Endokrinologie</name>
      <address>
        <city>Hannover</city>
        <state>Lower Saxony</state>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janina Kirschner</last_name>
      <phone>+49 511 532 3779</phone>
      <email>Kirschner.Janina@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Michael Manns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>QLD</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Remberg</last_name>
      <phone>499131/85-35194</phone>
      <email>annette.remberg@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Kremer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHARITÉ, Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>D-13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Baier</last_name>
      <phone>49 30 450565226</phone>
      <email>doreen.baier@charite.de</email>
    </contact>
    <investigator>
      <last_name>Eckart Schott</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univeritatsklinikum Hamburg Eppendorf, Medizinische Klinik und Poliklinik</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Aue-Raschka</last_name>
      <phone>4940741057981</phone>
      <email>k.aue-raschka@uke.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Schramm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Heidelberg Medizinische Universitaetsklinik</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Engelhardt</last_name>
      <phone>49 6221 56 31343</phone>
      <email>Silvia.Engelhardt@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Daniel Gotthardt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universität Leipzig KöR, Medizinische Fakultät</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madlen Steger</last_name>
      <phone>49341-97 24831</phone>
      <email>Madlen.Steger@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Wiegand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Munich, LMU Klinikum Grosshadern</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renate Atrmann</last_name>
      <phone>49 89 4400 73129</phone>
      <email>renate.artmann@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Simon Hohenster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rethy Pal Hospital</name>
      <address>
        <city>Bekescsaba</city>
        <zip>H-5600</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Opra</last_name>
      <phone>+36703896058</phone>
      <email>andreaopra79@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marta Varga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szent János Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>H-1125</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Szarvashegyi</last_name>
      <phone>+36204886171</phone>
      <email>marta.szarvashegyi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Margit Pusztay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Of Debrecen, Department Of Medicine, Division Of Gastroenterology</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Istvan Tornai</last_name>
      <phone>36309722826</phone>
      <email>itornai@med.unideb.hu</email>
    </contact>
    <investigator>
      <last_name>Istvan Tornai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <state>Nazareth Elit</state>
        <zip>POB 12000, 91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rami Ghantous</last_name>
      <phone>+972-54-7748258</phone>
      <email>ramighantous@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Rifaat Safadi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <zip>84104</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keren Moyal</last_name>
      <phone>972-8-6403582</phone>
      <email>KerenMo@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Ohad Etizon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rimma Kramskay</last_name>
      <phone>+972-4-7772017</phone>
      <email>rimma_k@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Tarek Saadi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031 02</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Armoni, BSC</last_name>
      <phone>972-2-6555467</phone>
      <email>danielarmoni@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Yoav Lurie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Schulamith Greenstein</last_name>
      <phone>972-3-9377254</phone>
      <email>ShulamithG@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Michal Cohen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <zip>52656 01</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avishag Hassid</last_name>
      <phone>972 3 5307176</phone>
      <email>Avishag.Hassid@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ziv Ben Ari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sourasky Tel-Aviv Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Livshitz</last_name>
      <phone>+972-3-6925796</phone>
      <email>marinaliv@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Oren Shibolet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero - Universitaria di Cagliari - Centro per lo Studio delle Malattie del Fegato</name>
      <address>
        <city>Monserrato</city>
        <state>Cagliari</state>
        <zip>09042</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cinzia Balestrieri</last_name>
      <phone>+39 70 51096098</phone>
      <email>cbalestrieri@aoucagliari.it</email>
    </contact>
    <investigator>
      <last_name>Luchino Chessa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Politecnica delle Marche - Azienda Ospedaliero</name>
      <address>
        <city>Ancona</city>
        <zip>71-60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Maroni</last_name>
      <phone>+39 071 5964600</phone>
      <email>luca.maroni@live.it</email>
    </contact>
    <investigator>
      <last_name>Marco Marzioni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Pol. S.Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marzia Margotti</last_name>
      <phone>+39 0512143627</phone>
      <email>marzia.margotti2@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Peietro Andreone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DIMEC- Alma Mater Studiorum Bologna-Sant'orsola Hospital</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgia Lazzarini</last_name>
      <phone>+39 0512143276</phone>
      <email>giorgia.lazzarini@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Mazzella</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Careggi</name>
      <address>
        <city>Florence</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirko Tarocchi</last_name>
      <phone>+390552758115</phone>
      <email>mirko.tarocchi@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Andrea Galli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Socio-Sanitarla Territoriale (ASST) Santi Paolo e Carlo</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Zuin, MD</last_name>
      <phone>390281844447</phone>
    </contact>
    <investigator>
      <last_name>Massimo Zuin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale (ASST) di Monza</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Gemma</last_name>
      <phone>+39 039 2332695</phone>
      <email>marta.gemma@unimib.it</email>
    </contact>
    <investigator>
      <last_name>Pietro Invernizzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dept Of Surgery, Oncology And Gastroenterology University Of Padua Italy</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Secchi</last_name>
      <phone>39 0498212889</phone>
      <email>mfrancesca.secchi@libero.it</email>
    </contact>
    <investigator>
      <last_name>Annarosa Floreani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico Paolo Giaccone - Di.Bi.M.I.S</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piero Almasio</last_name>
      <phone>+39 091 6553131</phone>
      <email>piero.almasio@unipa.it</email>
    </contact>
    <investigator>
      <last_name>Piero Luigi Almasio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Agostino Gemelli - Universita Cattolica del Sacro Cuore</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzina Morales</last_name>
      <phone>+39 06 30156018</phone>
      <email>vincenzina.mora@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maurizio Pompili</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggido</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Da Woon Jeong</last_name>
      <phone>82-10-4247-2247</phone>
      <email>r1159@snubh.org</email>
    </contact>
    <investigator>
      <last_name>Sook-Hyang Jeong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>602-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Sil Sohn</last_name>
      <phone>82-10-9182-2123</phone>
      <email>sohn0302@naver.com</email>
    </contact>
    <investigator>
      <last_name>Jeong Heo, Md, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inje University Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>614-735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Uk Jung, Ph.D.</last_name>
      <phone>82-51-890-6072</phone>
      <email>ukky77@naver.com</email>
    </contact>
    <investigator>
      <last_name>Youn-Jae Lee, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeong Eun Gim, SN</last_name>
      <phone>82 10 9900 3464</phone>
      <email>lovely5848@naver.com</email>
    </contact>
    <investigator>
      <last_name>Jung-Hwan Yoon, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Sook Do</last_name>
      <phone>82-2-10-9114-9066</phone>
      <email>djs1219@naver.com</email>
    </contact>
    <investigator>
      <last_name>Kwan Sik Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Lithuanian University of Health Sciences, Kauno klinikos</name>
      <address>
        <city>Kaunas</city>
        <zip>LT 50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vitalija Petrenkiene</last_name>
      <phone>+370 687 88336</phone>
      <email>vitalijapetrenkiene@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Limas Kupcinskas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hopital Santariskiu klinikos</name>
      <address>
        <city>Vilnius</city>
        <zip>LT-08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danute Speiciene, PhD</last_name>
      <phone>+370 686 17557</phone>
      <email>danute.speiciene@santa.lt</email>
    </contact>
    <investigator>
      <last_name>Jonas Valantinas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Departamento De Gastroenterologia. Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran</name>
      <address>
        <city>Mexico City</city>
        <state>DF</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosalba Avalos Martinez, QFB</last_name>
      <phone>00 52 55 5487 0900</phone>
      <phone_ext>1207</phone_ext>
      <email>rosyavalosm@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Francisco Sanchez-Avila, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consultorio Médico de la Dra Alma Laura Ladrón de Guevara Cetina</name>
      <address>
        <city>Mexico City</city>
        <state>DF</state>
        <zip>6700</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alma Laura Ladron-De-Guevara</last_name>
      <phone>525510546591</phone>
      <email>lauraldeg@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Alma Ladron-De-Guevara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Slaa</last_name>
      <phone>+31 24 361 9190</phone>
      <email>researchunit.mdl@radboudumc.nl</email>
    </contact>
    <investigator>
      <last_name>Joost Drenth, J.P.H.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vrije Universiteit Medisch Centrum (VUMC)</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1081HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renee DIerx</last_name>
      <phone>+31 20 4449450</phone>
      <email>r.dierx@vumc.nl</email>
    </contact>
    <investigator>
      <last_name>Dewkoemar Ramsoekh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Mc</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Brings</last_name>
      <phone>+31 (0)10 703 5291</phone>
      <email>i.brings@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Henk Van Buuren</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center (AMC)</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lowiek Hubers</last_name>
      <phone>31205669111</phone>
      <email>l.m.hubers@amc.uva.nl</email>
    </contact>
    <investigator>
      <last_name>Ulrich Beuers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Janneke van den Brink</last_name>
      <phone>+31 (0)88 755 9793</phone>
      <email>j.vandenbrink@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Karel Van Erpecum</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Grafton</city>
        <state>Auckland</state>
        <zip>1023</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lay Cunningham</last_name>
      <phone>64 9 307 4949</phone>
      <phone_ext>22932</phone_ext>
      <email>LayC@adhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>David Orr, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <state>Canterbury</state>
        <zip>4710</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rhondda Brown, RN</last_name>
      <phone>643 364 0135</phone>
      <email>rhondda.brown@cdhb.health.nz</email>
    </contact>
    <investigator>
      <last_name>Catherine Stedman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nzoz Vitamed</name>
      <address>
        <city>Bydgoszcz</city>
        <state>Kujawsko-Pomorskie</state>
        <zip>85-078</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafal Cichomski</last_name>
      <phone>48665102401</phone>
      <email>r.cichomski@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Michal Walczak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego, Pierwszy Oddzial Chorob Zakaznych</name>
      <address>
        <city>Wroclaw</city>
        <state>Lover Silesia</state>
        <zip>51-149</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serafinska Sylwia, MD</last_name>
      <phone>+48 604 987 041</phone>
      <email>sylwiaseraf@poczta.onet.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Simon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Warsaw Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie (SPCSK in Warsaw</name>
      <address>
        <city>Warsaw</city>
        <state>Masovia</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanna Raszeja-Wyszomirska</last_name>
      <phone>48 22 599 1662</phone>
      <email>jorasz@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Piotr Milkiewicz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Onkologii - Instytut im. Marii Skłodowskiej - Curie, Klinika Gastroenterologii Onkologicznej</name>
      <address>
        <city>Warsaw</city>
        <state>Mazovia</state>
        <zip>02-781</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Rawa, MD, PhD</last_name>
      <phone>48225462328</phone>
      <email>trawa@coi.waw.pl</email>
    </contact>
    <contact_backup>
      <phone>+48-22-5463044</phone>
    </contact_backup>
    <investigator>
      <last_name>Jaroslaw Regula, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oddział Gastr. I Hepat. Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibińskiego Sum</name>
      <address>
        <city>Katowice</city>
        <state>Silesia</state>
        <zip>40-752</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena Lesinska</last_name>
      <phone>+48327894418</phone>
      <email>magdalenalesinska79@poczta.fm</email>
    </contact>
    <investigator>
      <last_name>Marek Hartleb, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. Of Gastroenterology UM Lublin</name>
      <address>
        <city>Lublin</city>
        <zip>20-094</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Halina Cichoż-Lach</last_name>
      <phone>+49601377656</phone>
      <email>lach.halina@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Celinski, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic For Gastroenterology And Hepatology Clinical Center Of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Alempijevic</last_name>
      <phone>+381 11 3640620</phone>
      <email>tamara.alempijevic@med.bg.ac.rs</email>
    </contact>
    <investigator>
      <last_name>Miodrag Krstic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Centre Zvezdara</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dusica Kalem, MD</last_name>
      <phone>38163440693</phone>
      <email>kalemvrinic@mts.rs</email>
    </contact>
    <investigator>
      <last_name>Petar Svorcan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués De Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Estebanez</last_name>
      <phone>0034 942202544</phone>
      <email>aesga@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Javier Crespo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta De Hierro Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Gomez</last_name>
      <phone>+34 607 944 154</phone>
      <email>mgadelhuph@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Trapero-Marugan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Torrent</last_name>
      <phone>34932746240</phone>
      <email>mariacadaques52@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Victor Vargas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Sese</last_name>
      <phone>+34 93 227 57 53</phone>
      <email>pilar.sese1@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Albert Pares</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virgen De La Victoria University Hospital</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Moreno</last_name>
      <phone>34951032058</phone>
      <email>inmaculada.moreno@ciberehd.org</email>
    </contact>
    <investigator>
      <last_name>Raul Andrade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Carmen Rico</last_name>
      <phone>+34 600 162 875</phone>
      <email>mcricoguti@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Romero-Gomez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>La Fe, Hospital ( Valence )</name>
      <address>
        <city>Valence</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Hontangas, MD</last_name>
      <phone>+ 34 96 124 58 56</phone>
      <email>vahonpla@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marina Berenguer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mag/tarm lab</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angeli Lidén</last_name>
      <phone>+46 31 342 8107</phone>
      <email>angeli.liden@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Hanns-Ulrich Marschall</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pia Loqvist</last_name>
      <phone>+46 8 585 87122</phone>
      <email>pia.loqvist@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Staffan Wahlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital, University Of Bern, UVCM, DMLL</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathrin Husi</last_name>
      <phone>41 31 632 5933</phone>
      <email>kathrin.husi@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Guido Stirnimann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St. Gallen, Clinic for Gastroeterologie and Hepatologie</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Alfter, MSc</last_name>
      <phone>+41 71 494 27 67</phone>
      <email>christine.alfter@kssg.ch</email>
    </contact>
    <investigator>
      <last_name>David Semela, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USZ, Klinik für Gastroenterologie und Hepatologie</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Polzer</last_name>
      <phone>41 44 255 3757</phone>
      <email>claudia.polzer@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Beat Müllhaupt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine Gastroenterology Dept.</name>
      <address>
        <city>Ankara</city>
        <zip>6100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Güliz Konca</last_name>
      <phone>+905417897351</phone>
      <email>k.guliz@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Cihan Yurdaydin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ege University School of Medicine Gastroenterology Dept.</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esin Faralyali</last_name>
      <phone>+905530094625</phone>
      <email>cakilesin@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ulus Akarca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Bristol NHS Foundation Trust</name>
      <address>
        <city>Bristol</city>
        <state>Avon</state>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Wright</last_name>
      <phone>0117 342 3253</phone>
      <email>Louise.Wright@UHBristol.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Anne McCune</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Plymouth Hospitals NHS Trust</name>
      <address>
        <city>Plymouth</city>
        <state>Devon</state>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda March</last_name>
      <phone>01752 432644</phone>
      <email>lindamarch@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Matthew Cramp</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Infirmary/Gartnavel General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Lanarkshire</state>
        <zip>G12 0YN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Priest</last_name>
      <phone>+44 0141 451 6090</phone>
      <email>Matthew.Preist@ggc.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Matthew Priest</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Forth Valley Royal Hospital</name>
      <address>
        <city>Larbert</city>
        <state>Scotland</state>
        <zip>FK5 4WR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Newcastle University</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>Tyne And Wear</state>
        <zip>NE2 4HH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kath Houghton</last_name>
      <phone>+44 (0)191 2829885</phone>
      <email>Kathryn.Houghton@newcastle.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Dave Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jo Grayer</last_name>
      <phone>44 (0) 121 414 8276</phone>
      <email>Jo.Grayer@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Gideon Hirschfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Addenbrookes Hospital Department of Medicine, Level 5, Hepatology</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janeane Hails</last_name>
      <phone>01223 216109</phone>
      <email>janeane.hails@addenbrookes.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>George Mells</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Childs</last_name>
      <phone>020 7794 0500 Ext. 22521</phone>
      <email>n.childs@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Douglas Thorburn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospital Nhs Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Carlton</last_name>
      <phone>+44 01158 231475</phone>
      <email>Catherine.Carlton@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Stephen Ryder, B.Med.Sci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Denmark</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Former Serbia and Montenegro</country>
  </removed_countries>
  <reference>
    <citation>Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906.</citation>
    <PMID>19554543</PMID>
  </reference>
  <reference>
    <citation>European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009 Aug;51(2):237-67. doi: 10.1016/j.jhep.2009.04.009. Epub 2009 Jun 6.</citation>
    <PMID>19501929</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Biliary Cirrhosis</keyword>
  <keyword>PBC</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Liver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chenodeoxycholic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

